← All stocks

BillionToOne, Inc.

BLLN Scheduled selling only
CIK 0002070849 #1434 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$8.29M
$279.82K on a plan · $8.01M straight out of an exercise
Sold at will
$0.00
0 of 28 sales
Net
−$8.29M
$0.00 against sales at will

By person

13 insiders · 28 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Atay Oguzhan
Chairman and CEO
$3.03M (10) scheduled
−$3.03M
319,668
2.86%
$31.33M
−86.3%
Tsao David
Chief Technology Officer
$2.98M (3) scheduled
−$2.98M
1,000
0.0089%
$98.00K
−100.0%
Lynch Thomas P.
See Remarks
$2.00M (13) scheduled
−$2.00M
700
0.0063%
$68.60K
+16.7%
ten Bosch John Roderick
SVP of Laboratory Operations
$279.82K (2) scheduled
−$279.82K
25,051
0.2241%
$2.45M
−32.3%
Ileri Firat
Director
2,621,164
23.45%
$256.87M
Humming Bird Ventures Management NV entity
10% owner
2,580,833
23.09%
$252.92M
Rai Akshay
Director
1,798,440
16.09%
$176.25M
Bremner Thomas S
Director
704,493
6.30%
$69.04M
Sakakibara Shan Riku
Chief Product Officer
196,500
1.76%
$19.26M
−10.7%
NeoTribe Ventures I, L.P. entity
10% owner
87,362
0.7815%
$8.56M
KOLLURI KRISHNA KITTU
Director
69,189
0.6189%
$6.78M
Pagano Anthony
Director
7,913
0.0708%
$775.47K
Johnson Nancy JoAnn
See Remarks
6,900
0.0617%
$676.20K
−76.2%
Insider
Date
Role
Action
Shares
Price
Amount
ten Bosch John Roderick
9 Sep 2026
SVP of Laboratory Operations
Sold on a plan
1,416
$97.54
$138.12K
ten Bosch John Roderick
25 Aug 2026
SVP of Laboratory Operations
Sold on a plan
1,417
$100.00
$141.70K

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 26
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 721,185
History held since 10 Nov 2025